1. Home
  2. TVTX vs ARMN Comparison

TVTX vs ARMN Comparison

Compare TVTX & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • ARMN
  • Stock Information
  • Founded
  • TVTX 2008
  • ARMN 1992
  • Country
  • TVTX United States
  • ARMN Canada
  • Employees
  • TVTX N/A
  • ARMN N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • ARMN
  • Sector
  • TVTX Health Care
  • ARMN
  • Exchange
  • TVTX Nasdaq
  • ARMN Nasdaq
  • Market Cap
  • TVTX 2.5B
  • ARMN 2.0B
  • IPO Year
  • TVTX N/A
  • ARMN N/A
  • Fundamental
  • Price
  • TVTX $29.05
  • ARMN $9.57
  • Analyst Decision
  • TVTX Strong Buy
  • ARMN Strong Buy
  • Analyst Count
  • TVTX 15
  • ARMN 1
  • Target Price
  • TVTX $34.86
  • ARMN $17.00
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • ARMN 1.4M
  • Earning Date
  • TVTX 10-30-2025
  • ARMN 10-29-2025
  • Dividend Yield
  • TVTX N/A
  • ARMN N/A
  • EPS Growth
  • TVTX N/A
  • ARMN N/A
  • EPS
  • TVTX N/A
  • ARMN 0.02
  • Revenue
  • TVTX $333,865,000.00
  • ARMN $646,783,000.00
  • Revenue This Year
  • TVTX $83.23
  • ARMN $73.48
  • Revenue Next Year
  • TVTX $41.49
  • ARMN $56.35
  • P/E Ratio
  • TVTX N/A
  • ARMN $395.77
  • Revenue Growth
  • TVTX 87.94
  • ARMN 38.72
  • 52 Week Low
  • TVTX $12.91
  • ARMN $3.29
  • 52 Week High
  • TVTX $28.85
  • ARMN $11.24
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 73.62
  • ARMN 46.52
  • Support Level
  • TVTX $26.79
  • ARMN $9.06
  • Resistance Level
  • TVTX $28.24
  • ARMN $10.03
  • Average True Range (ATR)
  • TVTX 1.02
  • ARMN 0.45
  • MACD
  • TVTX -0.01
  • ARMN -0.18
  • Stochastic Oscillator
  • TVTX 100.00
  • ARMN 23.39

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About ARMN Aris Mining Corporation

Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.

Share on Social Networks: